More than 240 million people worldwide are chronically infected with hepatitis B virus (HBV).
Mother-to-child transmission remains the most important mechanism of infection in countries …

Hepatitis C virus (HCV) chronically infects about 2% of the world's population. Approximately
a quarter of these patients will develop, during their life, liver cirrhosis, which entails a high …

Although interferon‐free antiviral treatment is expected to improve treatment of hepatitis C, it
is unclear to what extent pre‐existing drug‐resistant amino acid substitutions influence …

A comprehensive stability indicating HPLC with diode array detection method was
developed for the determination of the recently approved antiviral drug daclatasvir …

The introduction of highly potent direct‐acting antivirals (DAAs) has revolutionized hepatitis
C virus treatment. Nevertheless, viral eradication worldwide remains a challenge also in the …

Introduction: About 150,000,000 people worldwide are chronically infected with hepatitis C
virus (HCV). HCV infection can lead to liver cirrhosis, hepatocellular carcinoma and death …

The combination of pegylated interferon (PEG-IFN) and ribavirin (RBV), the current therapy
for hepatitis C virus (HCV) infection, has saved the lives of many HCV-infected patients …

Abstract Background Hepatitis C virus (HCV) is a major global health problem, causing
chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Development of well …

About 240 million people worldwide are chronically infected with hepatitis B virus (HBV).
Vertical transmission is the most important mechanism of infection persistence in endemic …

Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin disease
characterized by defects in type VII collagen leading to a range of fibrotic pathologies …